+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Albendazole treatment in cystic echinococcosis: pharmacokinetics and clinical efficacy of two different aqueous formulations



Albendazole treatment in cystic echinococcosis: pharmacokinetics and clinical efficacy of two different aqueous formulations



Parasitology Research 103(2): 355-362



The pharmacokinetic (PK) behaviour and clinical efficacy of albendazole (ABZ) against hydatid cysts in mice were assessed after treatment with two different ABZ pharmaceutical formulations. BalbC mice received ABZ (0.5 mg/kg) prepared either as solution or suspension (50 microg/ml) for oral administration (PK study). Blood samples were collected up to 16 h post-treatment and processed to measure ABZ/metabolites concentrations in plasma. The clinical efficacy assessment was performed in BalbC mice infected 8 months earlier with Echinococcus granulosus protoscoleces. Infected animals were allocated into three experimental treatment groups: (a) untreated control, (b) ABZ-solution treated, (c) ABZ-suspension treated. Both treated groups received ABZ (0.5 mg/kg) administered under two different therapeutic schemes: dosing every 48 h over 30 days (regimen I) or treated every 12 h during 15 days (regimen II). Experimental mice were sacrificed 12 h after treatment, and cysts were recovered, weighed and processed for transmission electron microscopy. Enhanced ABZ sulphoxide (the main ABZ metabolite) concentration profiles were measured in animals treated with the ABZ solution. Any positive clinical response was obtained after treatment every 48 h (30 days therapy). However, consistent with the observed PK results, both ABZ formulations were clinically effective in infected mice treated with a 12-h dosing interval (15 days therapy).

(PDF emailed within 0-6 h: $19.90)

Accession: 029951333

Download citation: RISBibTeXText

PMID: 18465143

DOI: 10.1007/s00436-008-0980-x


Related references

A comparative trial of clinical efficacy of emulsion albendazole in treatment of hepatic cystic echinococcosis. Chinese Journal of Parasitic Disease Control 15(4): 228-229, 2002

Clinical effect and safety of liposomal-albendazole and tablet-albendazole for the treatment of human cystic echinococcosis. Zhonghua Gan Zang Bing Za Zhi 19(7): 532-536, 2012

Efficacy of albendazole emulsion in treatment of 212 patients with cystic echinococcosis. Chinese Journal of Parasitology and Parasitic Diseases 19(3): 129-134, 2001

Observations on clinical efficacy of albendazole emulsion in 264 cases of hepatic cystic echinococcosis. Parasitology International 53(1): 3-10, 2004

Enhanced chemoprophylactic and clinical efficacy of albendazole formulated as solid dispersions in experimental cystic echinococcosis. Veterinary Parasitology 203(1-2): 80-86, 2014

Comparative Evaluation of Liposomal Albendazole and Tablet-Albendazole Against Hepatic Cystic Echinococcosis: A Non-Randomized Clinical Trial. Medicine 95(4): E2237, 2016

Chemotherapy of human cystic echinococcosis: comparative efficacy of mebendazole and albendazole. Annals of Tropical Medicine and Parasitology 86(1): 59-66, 1992

An alternative mebendazole formulation for cystic echinococcosis: the treatment efficacy, pharmacokinetics and safety in mice. Parasites and Vectors 7: 589, 2015

Efficacy of Oxfendazole, Albendazole and Praziquantel against Cystic Echinococcosis in naturally infected sheep. 2007

Albendazole treatment of human cystic echinococcosis. Transactions of the Royal Society of Tropical Medicine and Hygiene 82(3): 453-459, 1988

Experience with Albendazole Treatment in Children with Cystic Echinococcosis. Meditsinskaia Parazitologiia i Parazitarnye Bolezni 2017(2): 9-13, 2017

Investigation on blood concentrations of albendazole sulfoxides in patients with cystic echinococcosis treated by emulsion albendazole. Endemic Diseases Bulletin 16(3): 64-66, 2001

Albendazole in treatment of human cystic echinococcosis: 12 years of experience. Acta Tropica 64(1-2): 79-93, 1997

Albendazole in treatment of human cystic echinococcosis: 12 years of experience. Acta Tropica 64(1/2): 79-93, 1996

Clinical efficacy of albendazole emulsion in treatment of 212 cases of liver cystic hydatidosis. Chinese Medical Journal 115(12): 1809-1813, 2003